LBX(SH:603883)2016-04-18 16:00Financial Performance - Operating revenue rose by 26.86% to CNY 1,328,880,702 year-on-year[5] - Net profit attributable to shareholders increased by 20.49% to CNY 79,069,962 compared to the same period last year[5] - The company reported a net profit of CNY 73,479,326, reflecting a 16.26% increase year-on-year[5] - Basic earnings per share decreased by 9.09% to CNY 0.30[5] - The company reported a total profit of ¥113,267,799 for Q1 2016, compared to ¥97,841,657 in Q1 2015, an increase of 15.7%[35] - Net profit for Q1 2016 was ¥88,361,954, representing a 17% increase from ¥75,551,079 in Q1 2015[35] - The net profit attributable to the parent company was ¥79,069,962, compared to ¥65,623,535 in the previous year, marking a 20% growth[35] Assets and Liabilities - Total assets increased by 8.83% to CNY 4,136,247,931 compared to the end of the previous year[5] - Total liabilities increased to CNY 1,755,890,293.00 from CNY 1,508,581,574.00, representing a growth of about 16.4%[29] - Current assets rose to CNY 2,612,160,017.00, up from CNY 2,328,188,634.00, indicating an increase of about 12.2%[27] - Total equity increased to CNY 2,380,357,638.00 from CNY 2,291,995,684.00, reflecting a growth of approximately 3.8%[29] - The company’s total assets reached ¥2,409,036,951, compared to ¥2,210,871,038 in the previous year, showing a growth of 9%[33] Cash Flow - Cash flow from operating activities was CNY 100,537,703, a slight increase of 0.07% year-on-year[5] - The company’s operating cash inflow for Q1 2016 was CNY 1,557,528,504, an increase of 26.9% compared to CNY 1,226,528,505 in the previous period[40] - The net cash flow from operating activities was CNY 100,537,703, slightly up from CNY 100,471,005 in the same period last year[41] - Cash inflow from financing activities was CNY 140,000,000, up from CNY 90,000,000 in the previous year, indicating a 55.6% increase[42] - The ending cash and cash equivalents balance was CNY 670,273,763, compared to CNY 259,692,610 at the end of the previous period, reflecting a 158.5% increase[42] Shareholder Information - The number of shareholders reached 31,083 at the end of the reporting period[10] - The largest shareholder, Zexing Investment Co., Ltd., holds 34.77% of the shares[10] Strategic Initiatives - The company is actively expanding its online and offline channels, focusing on O2O business development[14] - The company aims to enhance its procurement and distribution processes through three logistics centers, improving inventory turnover and reducing costs[14] - The company plans to issue up to 31 million shares to raise no more than RMB 129,612.86 million as part of its non-public offering[16] - The company plans to acquire 65% of the equity of Lanzhou Huirentang Pharmaceutical Chain Co., Ltd., using self-raised funds instead of the previously planned non-public offering[18] Compliance and Commitments - The company has held 3 board meetings, 2 supervisory board meetings, 1 audit committee meeting, and 3 compensation committee meetings during the reporting period, ensuring compliance with relevant laws and regulations[18] - The company is committed to complying with regulations from the China Securities Regulatory Commission and the stock exchange regarding share transfers[20] - The company will ensure compliance with legal requirements regarding share repurchase and investor compensation[21] - The company has pledged to return any funds and interest owed to the public if it violates its commitments, with the potential for freezing shares and withholding dividends as a remedy[24] Operational Adjustments - The company closed 10 stores during the reporting period as part of strategic operational adjustments[14] - The company received government subsidies and other cash related to operations amounting to RMB 10,447,817, an increase of 80.47%[13]